Results 181 to 190 of about 351,949 (320)

Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients. [PDF]

World J Urol
Krhut J, Hradílek P, Kondé A, Skugarevská B, Woznicová I, Sýkora RP, Kobberø H, Rychlý T, Zvara P.   +8 more
europepmc   +1 more source

EXPERIMENTAL STUDY ON MECHANISM OF URINARY TRACT INFECTIONS

, 1957
S Iwata, Seiichi Okayama
openalex   +2 more sources

First‐in‐Human Phase 1 Study to Evaluate the Clinical Pharmacology Properties of RBN‐3143, a Novel Inhibitor of Mono‐Adenosine Diphosphate Ribosyltransferase‐PARP14

Clinical Pharmacology in Drug Development, EarlyView.
Abstract RBN‐3143 is an inhibitor of PARP14 in development for inflammatory diseases. Multiple assessments were conducted to evaluate the clinical pharmacology properties of RBN‐3134. A randomized, double‐blind, placebo‐controlled study assigned healthy volunteers (HVs) to single ascending doses (SADs) (25‐1000 mg) or multiple ascending doses (MADs ...
Thomas M. Polasek, Alexandra Cole, Viviana Bozón, Erika Manyak, Jonathan Novak, Barbara Yang, Briohny A. Johnston, Sudha Parasuraman, Kushal J. Paneliya, Virna Schuck   +9 more
wiley   +1 more source

Primary urachal actinomycosis: A literature review

Asian Journal of Surgery, 2020
Jiaxuan Qin, Yuedong Chen, Jinchun Xing, Zonglong Cai   +3 more
doaj  

Is prostatic artery embolization a relevant treatment after a failed alpha-blocker monotherapy?

The Lancet Regional Health. Europe, 2023
Souhil Lebdai
doaj  

Invasive Urinary Tract Aspergillosis: A Rare Entity. [PDF]

Cureus
Jaouahar AA, Chahbi Z, Maoujoud O, Asserraji M, Zemraoui N.   +4 more
europepmc   +1 more source

Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity

Clinical Pharmacology &Therapeutics, EarlyView.
Polymyxins are used against highly resistant Gram‐negative pathogens, and nephrotoxicity (acute kidney injury, AKI) is the major dose‐limiting adverse effect. We aimed to develop a well‐informed population pharmacokinetic/toxicodynamic (PK/TD) model using the largest polymyxin B‐treated critically ill patient population studied to inform polymyxin B ...
Patrick O. Hanafin, Ramya Mahadevan, Gauri G. Rao, Alexandre P. Zavascki, Ana Maria Sandri, Andrea Kwa, Marc H. Scheetz, Christine J. Kubin, Jayesh Shah, Benjamin P.Z. Cherng, Michael T. Yin, Jiping Wang, Lu Wang, David P. Calfee, Maureen Bolon, Anthony W. Purcell, Roger L. Nation, Jason M. Pogue, Jian Li, Keith S. Kaye   +19 more
wiley   +1 more source

Urinary tract infections after menopause. [PDF]

CMAJ
Brennand EA, Holroyd-Leduc J.
europepmc   +1 more source

Cyclophosphamide and the urinary tract [PDF]

Internal Medicine Journal, 2002
openaire   +3 more sources

Candidiasis of the Urinary Tract [PDF]

Proceedings of the Royal Society of Medicine, 1974
J T Hill, D Williams
openaire   +3 more sources